NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ICICI Lombard General Insurance Company

Key Highlights

  • ICICI Lombard (ICICIGI) reported a 25.4% growth in earnings between FY22 and FY25, with a 11.3% YoY growth in 9MFY26 (7.5% ex-capital gains).
  • The company's 5-year earnings Compound Annual Growth Rate (CAGR) stands at 16%, indicating compounding potential.

Business Performance

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Despite sectoral challenges, including lower motor growth and higher loss ratios, ICICIGI has shown signs of improvement. Motor and health insurance segments are expected to recover, leading to an improvement in investment leverage, a key factor for rerating.

Valuation and Outlook

We maintain a BUY rating for ICICIGI with an unchanged Target Price (TP) of INR 2,250, based on 28x FY28E EPS of INR 79.4. Key risks include increased competitive intensity, rise in health claims, and lower-than-expected industry growth.

Recommendation

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

ICICIGI's healthy earnings growth, improving sectoral trends, and attractive valuations make the stock a favorable investment opportunity.

Investor Takeaway

Investors should consider maintaining a BUY rating for ICICI Lombard General Insurance Company with a target price of INR 2,250.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.